home / stock / pdsb / pdsb news

PDSB News and Press, PDS Biotechnology Corporation From 03/11/21

Stock Information
Company Name: PDS Biotechnology Corporation
Stock Symbol: PDSB
Market: NASDAQ
Website: pdsbiotech.com
Menu
PDSB PDSB Quote PDSB Short PDSB News PDSB Articles PDSB Message Board
Get PDSB Alerts

News, Short Squeeze, Breakout and More Instantly...
PDSB - PDS Biotech Announces that its COVID-19 Vaccine Consortium Received a Commitment from The Ministry of Science, Technology and Innovation of Brazil (MCTI) to fund Clinical Development and Commercialization of a Versamune®-Based COVID-19 Vaccine with a

FLORHAM PARK, N.J., March 11, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines based on PDS Biotech’s proprietary Versamune ® T-cell activating tech...
PDSB - PDS Biotechnology Announces Conference Call and Webcast for Fourth Quarter and Full Year 2020 Financial Results

FLORHAM PARK, N.J., March 08, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines based on the Company’s proprietary Versamune® T-cell activating technolog...

PDSB - PDS Biotech Announces Presentations in Upcoming Healthcare Investor Conferences

FLORHAM PARK, N.J., March 03, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines based on the Company’s proprietary Versamune® T-cell activating technolog...

PDSB - Extensive Demand for T-Cell Adoptive Immunotherapy Rising with Growing Prevalence of Cancer

Palm Beach, FL –February 23, 2021 – In the breast cancer therapy market, the rise in the prevalence of cancer, has propelled the T-cell therapy market over the last few years and it is projected to continue to do so for several years to come. T-cell therapy includes using gene...
PDSB - PDS Biotech and Farmacore Announce Blanver to Join Consortium to Commercialize Novel Versamune®-Based T-Cell Inducing COVID-19 Vaccine

FLORHAM PARK, N.J., Feb. 22, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines based on the Company’s proprietary Versamune® T-cell activating technology...

PDSB - VXRT, GWPH, OCGN and SAVA among midday movers

Gainers: Tyme Technologies (TYME) +93%.Sino-Global Shipping America (SINO) +81%.Lizhi (LIZI) +70%.Cassava Sciences (SAVA) +48%.GW Pharmaceuticals (GWPH) +46%.CPS Technologies (CPSH) +41%.10X Capital Venture Acquisition (VCVC) +38%.Naked Brand (NAKD) +37%.SuperCom (SPCB) +34%.Am...

PDSB - PDS Biotech announces preliminary efficacy readout from phase 2 combo trial of PDS0101

PDS Biotechnology ([[PDSB]] -10.8%) announced that the National Cancer Institute’s ((NCI)) Phase 2 clinical study of PDS0101, for the treatment of advanced human papillomavirus ((HPV))-associated cancers that have progressed or returned after treatment, achieved its preliminary ob...
PDSB - Tyme Technologies, GW Pharmaceuticals leads healthcare gainers; Vaxart, Moleculin Biotech among major losers

Gainers: Tyme Technologies (TYME) +110%, GW Pharmaceuticals (GWPH) +47%, Zynerba Pharmaceuticals (ZYNE) +39%, SELLAS Life Sciences (SLS) +38%, InMed Pharmaceuticals (INM) +15%.Losers: Vaxart (VXRT) -51%, Moleculin Biotech (MBRX) -26%...

PDSB - PDS Biotech Announces Preliminary Efficacy Achievement in Phase 2 Combination Trial of PDS0101 Led by the National Cancer Institute

FLORHAM PARK, N.J., Feb. 03, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines based on the Company’s proprietary Versamune® T-cell activating technology...

PDSB - Making A List Of Hot Penny Stocks? 4 Biotech Stocks To Watch This Week

Are These Biotech Names On Your List Of Penny Stocks Right Now? Are you looking for penny stocks to buy right now? If you are, you’re not alone. These cheap stocks have attracted the masses recently, and for a good reason. The strength of retail trading groups has become a cl...
Previous 10 Next 10